Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
1.
Transfus Clin Biol ; 15(6): 390-4, 2008 Dec.
Article in French | MEDLINE | ID: mdl-18930683

ABSTRACT

The need to adapt red blood cells concentrates management in surgery blocs and resuscitation to the changes of the legal framework has lead to a collective approach to improve practices. Gathered by the regional hemovigilance coordinators of the Drass Ile-de-France (regional office of health and social actions), representatives of doctors' ordering transfusions and hemovigilance correspondents of the Assistance publique-Hôpitaux de Paris and representatives of the EFS (French blood establishment) Ile-de-France, together with representatives of the Afssaps (French health products safety agency), have coordinated an assessment of local transfusion practices in surgery blocs and resuscitation that have to be compliant. Each hospital then offered local improvement actions, approved by regional and national instances. We present this original and collective approach of assessing practices leading to offers that both respond to a legal framework and improve blood products flows without damaging transfusion security.


Subject(s)
Erythrocyte Transfusion/statistics & numerical data , Erythrocyte Transfusion/legislation & jurisprudence , Erythrocyte Transfusion/standards , France , Humans , Legislation, Medical , Postoperative Period , Public Health , Resuscitation , Safety
3.
J Clin Endocrinol Metab ; 82(1): 32-8, 1997 Jan.
Article in English | MEDLINE | ID: mdl-8989228

ABSTRACT

Calcium stone formers (CaSF) with idiopathic hypercalciuria (IH) have been shown to have decreased bone mineral density (BMD). The mechanism of their bone loss remains obscure. Monokines like interleukin-1 beta (IL-1 beta), IL-6, tumor necrosis factor-alpha (TNF-alpha), and granulocyte macrophage stimulating factor (GM-CSF) are involved in bone remodeling, but only IL-1 excess has been incriminated in the bone loss of CaSF with IH. Therefore, to more precisely delineate the role of monocyte activation in the pathogenesis of bone loss in these patients, we studied the production of IL-1 beta, IL-6, TNF-alpha, and GM-CSF by unstimulated or lipopolysaccharide (LPS)-stimulated cultured peripheral blood monocytes in 15 CaSF with IH, in 10 CaSF with dietary calcium-dependent hypercalciuria (DH), and in 10 healthy controls (C). Cytokines were measured in the culture medium by sensitive enzyme-linked immunosorbent assay and vertebral BMD by single energy computed tomography. The decrease of vertebral BMD in IH compared with DH, was confirmed (Z score: -1.2 +/- 0.2 vs. -0.5 +/- 0.2; P = 0.04; Mann-Whitney). In the supernatant of unstimulated peripheral blood monocytes, IL-1 beta and TNF-alpha levels were higher in IH than in C (respectively, 40 +/- 21 vs. 7 +/- 1 pg/mL, P = 0.008 and 236 +/- 136 vs. 39 +/- 23 pg/mL, P = 0.03); those of GM-CSF were greater in IH than in DH and C (respectively, 52 +/- 27 vs. 6 +/- 2, P = 0.04 and 6 +/- 2 pg/mL, P = 0.01) and those of IL-6 were not significantly different among the groups. After in vitro stimulation by LPS (10 micrograms/mL), the levels of the various monokines were not significantly different. In IH patients, the post-LPS levels of IL-6 were negatively correlated to vertebral BMD (n = 15, Z = -1.97, P = 0.04; Spearman), whereas those of GM-CSF were positively related to vertebral BMD (n = 15, Z = 2.01, P = 0.04). In this study, calcium stone formers with IH have bone mineral decrease and a particular profile of peripheral blood monocytes activation. This latter is characterized by a spontaneously increased synthesis of IL-1 beta, TNF-alpha, and GM-CSF. Furthermore, post-LPS levels of IL-6 and GM-CSF are correlated with vertebral BMD. These results suggest that monocyte activation may be involved in the bone loss of calcium stone formers with IH.


Subject(s)
Bone Density , Calcium/analysis , Calcium/urine , Kidney Calculi/chemistry , Kidney Calculi/physiopathology , Monocytes/physiology , Adult , Female , Granulocyte-Macrophage Colony-Stimulating Factor/metabolism , Humans , Interleukin-1/metabolism , Interleukin-6/metabolism , Lipopolysaccharides/pharmacology , Male , Middle Aged , Tumor Necrosis Factor-alpha/metabolism
4.
Blood ; 87(5): 1692-7, 1996 Mar 01.
Article in English | MEDLINE | ID: mdl-8634413

ABSTRACT

A signal transduction pathway activated by many cytokines has recently been elaborated. The JAK kinases and the signal transducers and activators of transcription (STAT) factors have been found to be essential components. In this report, we describe the presence of constitutively activated STAT factors in peripheral blood cells from patients with acute leukemia. We used oligonucleotide probes from the beta-casein and IRF-1 gene promoters and the ISRE probe to detect STAT proteins in nuclear extracts from acute leukemia cells in bandshift assays. Specific DNA protein complex formation was observed with the probes from the beta-casein and IRF-1 gene promoters, but not with the ISRE oligonucleotide probe, when cell extracts from acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) were investigated. We used nonradioactive oligonucleotides as competitors to show the specificity of the complex formation. Specific antibodies directed against the individual STAT proteins were used in supershift experiments. STAT5- and STAT1-related factors were detected in ALL and STAT1-, STAT3-, and STAT5-related proteins were present in nuclear cell extracts from AML. Since the cells were not treated with cytokines before the nuclear proteins were extracted, we conclude that these factors are constitutively activated in vivo. It is likely that the constitutive activation of STAT proteins is a part of the events of leukemogenesis.


Subject(s)
Blood Cells/metabolism , DNA-Binding Proteins/blood , Gene Expression Regulation, Leukemic , Leukemia/blood , Milk Proteins , Neoplasm Proteins/blood , Neoplastic Stem Cells/metabolism , Signal Transduction , Trans-Activators/blood , Acute Disease , Adult , Aged , Base Sequence , DNA, Neoplasm/blood , Humans , Leukemia/genetics , Macromolecular Substances , Molecular Sequence Data , Promoter Regions, Genetic , STAT1 Transcription Factor , STAT3 Transcription Factor , STAT5 Transcription Factor , Transcription, Genetic
5.
Blood ; 87(6): 2354-60, 1996 Mar 15.
Article in English | MEDLINE | ID: mdl-8630398

ABSTRACT

Recent reports describe the beneficial use of alpha interferon (IFNalpha) for the treatment of idiopathic hypereosinophilic syndrome (HES) unresponsive to conventional therapy. A clinical improvement associated with a rapid decrease of peripheral blood eosinophilia suggested possible direct effects of IFNalpha on eosinophils through the presence of IFNalpha receptors (IFNalphaR). Reverse transcriptase-polymerase chain reaction (RT-PCR) and cytochemistry were used respectively to detect the presence and define the distribution of IFNalphaR on enriched eosinophil preparations purified from blood cells. IFNalphaR was found on eosinophils collected from patients with various eosinophilic disorders. In addition, IFNalpha inhibited the release of eosinophil granule proteins such as eosinophil cationic protein (ECP), neurotoxin (EDN, or interleukin-5 (IL-5). Moreover, antiparasite cytotoxicity was also strongly reduced in a dose-dependent manner by IFNalpha. These results provide the first evidence that human eosinophils express a functional receptor for IFNalpha and represent a potential basis for the beneficial effects of IFNalpha in patients with hypereosinophilic syndromes.


Subject(s)
Blood Proteins/metabolism , Eosinophilia/blood , Eosinophils/metabolism , Interferon-alpha/pharmacology , Interleukin-5/metabolism , Neurotoxins/metabolism , Receptors, Interferon/metabolism , Ribonucleases , Animals , Antibody-Dependent Cell Cytotoxicity/drug effects , Base Sequence , Cytoplasmic Granules/metabolism , Depression, Chemical , Eosinophil Granule Proteins , Eosinophil-Derived Neurotoxin , Eosinophils/drug effects , Humans , Hypereosinophilic Syndrome/blood , Interferon alpha-2 , Interferon-alpha/metabolism , Molecular Sequence Data , Polymerase Chain Reaction , Receptor, Interferon alpha-beta , Recombinant Proteins , Schistosoma mansoni , Secretory Rate/drug effects
6.
Transfus Clin Biol ; 3(3): 157-65, 1996.
Article in French | MEDLINE | ID: mdl-8925110

ABSTRACT

Blood transfusion is mainly bound to immunological and infectious risks. The immunological risk originates from an incompatibility between the blood of the donor and that of the recipient; this risk remains insufficiently assessed. A multicentre study has been carried out by the French Blood Transfusion Society and the National Institute for Blood Transfusion. Sixty-one accidents due to an erythrocyte incompatibility were found: 26 cases with ABO incompatibility, and 35 cases with alloantibodies of other blood group systems. For the former category of accidents, the most frequent cause was due to a failure in the realization of the bedside ABO check. For the latter, the main problem was the achievement and the interpretation of antibody screening. The long term follow-up shows no chronic after-effects of immunological accidents. For each accident, errors have been identified and analysed. It was proven that they all originate from health care establishments.


Subject(s)
ABO Blood-Group System/immunology , Blood Group Incompatibility , Erythrocytes/immunology , Transfusion Reaction , Adult , Aged , Aged, 80 and over , Blood Preservation , Clinical Laboratory Techniques , Female , Follow-Up Studies , Humans , Isoantibodies/blood , Male , Medical Errors , Middle Aged , Risk Assessment
7.
Transfus Clin Biol ; 1(2): 135-40, 1994.
Article in French | MEDLINE | ID: mdl-8019648

ABSTRACT

Ultrasound interferometry is a new methodology which has been developed in our laboratories in order to measure precisely and quickly the size of particles sedimenting in liquid on horizontal surface, upon gravity. Applied to red blood cells, this method evaluates the sedimentation of erythrocytes, their aggregation induced by proteins or aggregating compounds as well as their agglutination upon immune reactions. The quantitative assessment of red cell agglutination was applied to the study of blood groups and to the search for red cell antibodies. Preliminary results show that ultrasound interferometry is 1) quantitative, measuring the size of agglutinates; 2) sensitive; 3) specific; 4) fast; 5) able to detect irregular antibodies.


Subject(s)
Hemagglutination Tests/methods , Interferometry/methods , Erythrocytes/immunology , Humans , Particle Size , Sensitivity and Specificity , Ultrasonics
8.
Transfus Clin Biol ; 1(1): 27-34, 1994.
Article in French | MEDLINE | ID: mdl-8186850

ABSTRACT

Transfusion therapy for sickle cell anemia is limited by the development of antibodies to red cell antigens. The aim of this study was to evaluate whether transfusion of blood matched for antigens Rh and Kell would reduce the incidence of alloimmunization. We determined the transfusion history, red cell phenotype and development of alloantibodies in 173 patients with sickle all anemia who received transfusions. Forty nine patients were transfused exclusively with frozen red blood cells (RBL) matched for antigens Rh and Kell; the rate of alloimmunization was 8.2%; antibodies to the Jkb, Jka, Fya and S were developed; 1 patient developed 2 antibodies. In a control group of 124 patients who received standard red blood cells, the rate of alloimmunization was significantly increased to 30.6% (p < 0.05); antibodies against C, E, K, Fya were the most frequently developed and 19 patients (16%) developed antibodies reacting with different antigens. In the 2 groups, alloimmunization occurred after receiving a significantly different number of transfusions: mean 9 in the patients transfused with matched RBC and 32 in the control group. The influence of the kinetics of transfusion was not demonstrated. To assess the effect that racial differences might have on alloimmunization, comparison of the red cell phenotype of patients with that of a panel of unselected blood bank donors was performed: the patients had a significant decrease in the frequency of red cell antigens corresponding to most of the detected alloantibodies JkB, C, S. Fyb, Fya and Kell.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Anemia, Sickle Cell/therapy , Blood Transfusion , Erythrocytes/immunology , Isoantibodies/blood , Kell Blood-Group System/immunology , Rh Isoimmunization/prevention & control , Adolescent , Adult , Aged , Anemia, Sickle Cell/blood , Anemia, Sickle Cell/immunology , Child, Preschool , Female , HLA Antigens/immunology , Humans , Male , Middle Aged , Phenotype
SELECTION OF CITATIONS
SEARCH DETAIL
...